Relay Therapeutics Inc.

12/11/2024 | Press release | Distributed by Public on 12/11/2024 05:00

Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.